Condition: Liver Metastases · Colorectal Cancer · Anal Canal Cancer · Sponsor: University of Sao Paulo
This is a Phase II study to determine the efficacy of SBRT to treat liver metastases in patients with Colorectal Adenocarcinoma, Carcinoma of the Anal Canal and Gastrointestinal Neuroendocrine Tumors that are not amenable to surgery. Patients should have no evidence of extra-hepatic disease or have disease that is planned to be treated with curative intent. Therefore, SBRT is being considered as a potentially curative procedure.
This description comes directly from the study's public registry record.
Andre TC Chen, MD, PhD · 55-11- 3893-4540 · andre.chen@hc.fm.usp.br
Karina Moutinho, MD · 55-11-3893-4542 · kamoutinho@gmail.com
Always discuss trial participation with your own doctor first.
| Instituto do Cancer do Estado de São Paulo | São Paulo, São Paulo, Brazil | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02185443